As deregulation of protein kinases (e.g., activation by gain-of-function genetic mutation, gene amplification, autonomous activation, and chromosomal rearrangement) has been associated with cancer development and progression21–24, protein kinases have been regarded as important targets for developing molecular targeted therapies. Here, WEE1 is linked to cancer.